Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $213,945.64 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas P. Wagner sold 14,878 shares of the stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $14.38, for a total transaction of $213,945.64. Following the transaction, the insider now directly owns 200,885 shares in the company, valued at approximately $2,888,726.30. This represents a 6.90 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Alignment Healthcare Trading Up 1.0 %

Alignment Healthcare stock traded up $0.14 during mid-day trading on Wednesday, reaching $14.52. 994,579 shares of the company traded hands, compared to its average volume of 1,842,446. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The firm’s 50 day moving average price is $12.84 and its 200 day moving average price is $11.52. The firm has a market capitalization of $2.78 billion, a price-to-earnings ratio of -18.86 and a beta of 1.50. Alignment Healthcare, Inc. has a 52-week low of $4.46 and a 52-week high of $15.82.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in ALHC. R Squared Ltd bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at $55,000. nVerses Capital LLC bought a new stake in shares of Alignment Healthcare during the 3rd quarter valued at $95,000. Ballentine Partners LLC bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at $121,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Alignment Healthcare during the 3rd quarter valued at $131,000. Finally, Aigen Investment Management LP bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at $129,000. 86.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ALHC. Stifel Nicolaus increased their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a report on Tuesday, January 14th. Barclays raised their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. Stephens reiterated an “overweight” rating and set a $17.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 2nd. Finally, UBS Group boosted their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a report on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.